title: Mitochondrial dysfunction and pathology in bipolar disorder and schizophrenia.
abstract: Bipolar disorder (BPD) and schizophrenia (SZ) are severe psychiatric illnesses with a combined prevalence of 4%. A disturbance of energy metabolism is frequently observed in these disorders. Several pieces of evidence point to an underlying dysfunction of mitochondria: (i) decreased mitochondrial respiration; (ii) changes in mitochondrial morphology; (iii) increases in mitochondrial DNA (mtDNA) polymorphisms and in levels of mtDNA mutations; (iv) downregulation of nuclear mRNA molecules and proteins involved in mitochondrial respiration; (v) decreased high-energy phosphates and decreased pH in the brain; and (vi) psychotic and affective symptoms, and cognitive decline in mitochondrial disorders. Furthermore, transgenic mice with mutated mitochondrial DNA polymerase show mood disorder-like phenotypes. In this review, we will discuss the genetic and physiological components of mitochondria and the evidence for mitochondrial abnormalities in BPD and SZ. We will furthermore describe the role of mitochondria during brain development and the effect of current drugs for mental illness on mitochondrial function. Understanding the role of mitochondria, both developmentally as well as in the ailing brain, is of critical importance to elucidate pathophysiological mechanisms in psychiatric disorders.
authors.affiliation: Neuroscience Graduate Program, Vanderbilt University, Nashville, TN 37232, USA.
authors.forename: Hayley B
authors.initials: HB
authors.lastname: Clay
authors.forename: Stephanie
authors.initials: S
authors.lastname: Sillivan
authors.forename: Christine
authors.initials: C
authors.lastname: Konradi
mesh_terms: D000818:Animals; D014150:Antipsychotic Agents / Q000494:pharmacology / Q000627:therapeutic use; D017209:Apoptosis; D001714:Bipolar Disorder / Q000188:drug therapy / Q000235:genetics / Q000473:pathology* / Q000503:physiopathology*; D001921:Brain / Q000254:growth & development / Q000473:pathology / Q000503:physiopathology; D002118:Calcium / Q000378:metabolism; D004249:DNA Damage; D004734:Energy Metabolism / Q000502:physiology; D006801:Humans; D008928:Mitochondria / Q000187:drug effects / Q000235:genetics / Q000473:pathology* / Q000502:physiology*; D028361:Mitochondrial Diseases / Q000473:pathology / Q000503:physiopathology; D009154:Mutation; D010085:Oxidative Phosphorylation; D018384:Oxidative Stress; D010641:Phenotype; D011110:Polymorphism, Genetic; D012333:RNA, Messenger / Q000378:metabolism; D012559:Schizophrenia / Q000188:drug therapy / Q000235:genetics / Q000473:pathology* / Q000503:physiopathology*
chemical_list: D014150:Antipsychotic Agents; D012333:RNA, Messenger; D002118:Calcium